Uchenna A. Nwosu

Uchenna Nwosu practices at Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA.

Uchenna Nwosu's NPI, 1881199727, was assigned on March 23, 2018. Uchenna Nwosu graduated from Meharry Medical College School of Medicine in 2018. Uchenna Nwosu's California license number on file is A167116.

Uchenna Nwosu's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center, at 1001 Potrero Avenue, San Francisco, CA 94110 in San Francisco County. The practice phone is (415) 206-8000.

Uchenna Nwosu's primary practice is Zuckerberg San Francisco General Hospital and Trauma Center in San Francisco, California, part of City and County of San Francisco, CA. Uchenna Nwosu is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Uchenna Nwosu to 1 more hospital, 5 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Uchenna Nwosu practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Uchenna Nwosu's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Uchenna Nwosu is board certified in internal medicine by the American Board of Internal Medicine. Uchenna Nwosu has a license on file in California.

CMS data shows 257 Medicare services from Uchenna Nwosu across 7 procedure codes in 2024, for 121 Medicare patients. Medicare paid $19,833 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 121 Medicare patients who saw Uchenna Nwosu in 2024. The largest group is 75 to 84, with 45 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 63% are also on Medicaid. Their average risk score is 4.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Uchenna Nwosu's median patient age at 73, with 41% women.

In 2024, Uchenna Nwosu wrote 46 Medicare Part D claims for 21 patients. 89% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $238 in total drug cost. In 2020, CMS named 23 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Uchenna Nwosu for performance year 2024, reported as part of a group. Uchenna Nwosu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Uchenna Nwosu as offering telehealth.

Dmand AI links 1 paper to Uchenna Nwosu. Uchenna Nwosu's most frequent co-authors are Hasmik Arzumanyan, MD, Kenneth K. Chen, MD and Joan C. Lo, MD.

CMS Open Payments shows 5 general payments to Uchenna Nwosu from 2 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Cardiovascular Systems Inc. paid the most, $318.

Uchenna Nwosu graduated from Meharry Medical College School of Medicine in 2018.

Uchenna Nwosu is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.